Global Pediatric Drugs Market Insights, Forecast to 2029

Publisher Name :
Date: 30-May-2023
No. of pages: 119
Inquire Before Buying

The market for pediatric pharmaceuticals has become an increasingly important tool in life-cycle management. However, line extensions using children's formulations to increase patent life of existing adult dose drugs are only one of the drivers of this large, but little-studied market.

The global Pediatric Drugs market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pediatric Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Pediatric Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Pediatric Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key manufacturers of Pediatric Drugs include Abbott Laboratories, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Colgate Oral Pharmaceuticals, Eli Lilly, Forest Laboratories, Genentech and GlaxoSmithKline, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Pediatric Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Pediatric Drugs, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pediatric Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pediatric Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Pediatric Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Pediatric Drugs sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott Laboratories, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Colgate Oral Pharmaceuticals, Eli Lilly, Forest Laboratories, Genentech and GlaxoSmithKline, etc.

By Company

- Abbott Laboratories

- Bayer

- Boehringer Ingelheim

- Bristol-Myers Squibb

- Colgate Oral Pharmaceuticals

- Eli Lilly

- Forest Laboratories

- Genentech

- GlaxoSmithKline

- Johnson & Johnson

- MedImmune

- Merck

- Novartis Pharmaceuticals

- Novo Nordisk

- Pfizer

- Pharmacia

- Roche

- Schering-Plough

Segment by Type

- Allergy and Respiratory Drugs

- Anti-Infectives

- Cancer Therapies

- Cardiovascular Drugs

- Central Nervous System Drugs

- Gastrointestinal Drugs

- Hormone Drugs

- Urological Drugs

Segment by Application

- Hospital

- Clinic

- Drugstore

Segment by Region

- US & Canada

- - U.S.

- - Canada

- China

- Asia (excluding China)

- - Japan

- - South Korea

- - China Taiwan

- Southeast Asia

- - India

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Middle East, Africa, Latin America

- - Brazil

- - Mexico

- - Turkey

- - Israel

- - GCC Countries

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Pediatric Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Pediatric Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pediatric Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Global Pediatric Drugs Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Pediatric Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Pediatric Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Allergy and Respiratory Drugs
1.2.3 Anti-Infectives
1.2.4 Cancer Therapies
1.2.5 Cardiovascular Drugs
1.2.6 Central Nervous System Drugs
1.2.7 Gastrointestinal Drugs
1.2.8 Hormone Drugs
1.2.9 Urological Drugs
1.3 Market by Application
1.3.1 Global Pediatric Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pediatric Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Pediatric Drugs Revenue by Region
2.2.1 Global Pediatric Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pediatric Drugs Revenue by Region (2018-2023)
2.2.3 Global Pediatric Drugs Revenue by Region (2024-2029)
2.2.4 Global Pediatric Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Pediatric Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Pediatric Drugs Sales by Region
2.4.1 Global Pediatric Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pediatric Drugs Sales by Region (2018-2023)
2.4.3 Global Pediatric Drugs Sales by Region (2024-2029)
2.4.4 Global Pediatric Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pediatric Drugs Sales by Manufacturers
3.1.1 Global Pediatric Drugs Sales by Manufacturers (2018-2023)
3.1.2 Global Pediatric Drugs Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pediatric Drugs in 2022
3.2 Global Pediatric Drugs Revenue by Manufacturers
3.2.1 Global Pediatric Drugs Revenue by Manufacturers (2018-2023)
3.2.2 Global Pediatric Drugs Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Pediatric Drugs Revenue in 2022
3.3 Global Key Players of Pediatric Drugs, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Pediatric Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pediatric Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pediatric Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pediatric Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Pediatric Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pediatric Drugs Sales by Type
4.1.1 Global Pediatric Drugs Historical Sales by Type (2018-2023)
4.1.2 Global Pediatric Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Pediatric Drugs Sales Market Share by Type (2018-2029)
4.2 Global Pediatric Drugs Revenue by Type
4.2.1 Global Pediatric Drugs Historical Revenue by Type (2018-2023)
4.2.2 Global Pediatric Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pediatric Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Pediatric Drugs Price by Type
4.3.1 Global Pediatric Drugs Price by Type (2018-2023)
4.3.2 Global Pediatric Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Pediatric Drugs Sales by Application
5.1.1 Global Pediatric Drugs Historical Sales by Application (2018-2023)
5.1.2 Global Pediatric Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Pediatric Drugs Sales Market Share by Application (2018-2029)
5.2 Global Pediatric Drugs Revenue by Application
5.2.1 Global Pediatric Drugs Historical Revenue by Application (2018-2023)
5.2.2 Global Pediatric Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pediatric Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Pediatric Drugs Price by Application
5.3.1 Global Pediatric Drugs Price by Application (2018-2023)
5.3.2 Global Pediatric Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Pediatric Drugs Market Size by Type
6.1.1 US & Canada Pediatric Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Pediatric Drugs Revenue by Type (2018-2029)
6.2 US & Canada Pediatric Drugs Market Size by Application
6.2.1 US & Canada Pediatric Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Pediatric Drugs Revenue by Application (2018-2029)
6.3 US & Canada Pediatric Drugs Market Size by Country
6.3.1 US & Canada Pediatric Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pediatric Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Pediatric Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pediatric Drugs Market Size by Type
7.1.1 Europe Pediatric Drugs Sales by Type (2018-2029)
7.1.2 Europe Pediatric Drugs Revenue by Type (2018-2029)
7.2 Europe Pediatric Drugs Market Size by Application
7.2.1 Europe Pediatric Drugs Sales by Application (2018-2029)
7.2.2 Europe Pediatric Drugs Revenue by Application (2018-2029)
7.3 Europe Pediatric Drugs Market Size by Country
7.3.1 Europe Pediatric Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pediatric Drugs Sales by Country (2018-2029)
7.3.3 Europe Pediatric Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pediatric Drugs Market Size
8.1.1 China Pediatric Drugs Sales (2018-2029)
8.1.2 China Pediatric Drugs Revenue (2018-2029)
8.2 China Pediatric Drugs Market Size by Application
8.2.1 China Pediatric Drugs Sales by Application (2018-2029)
8.2.2 China Pediatric Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pediatric Drugs Market Size by Type
9.1.1 Asia Pediatric Drugs Sales by Type (2018-2029)
9.1.2 Asia Pediatric Drugs Revenue by Type (2018-2029)
9.2 Asia Pediatric Drugs Market Size by Application
9.2.1 Asia Pediatric Drugs Sales by Application (2018-2029)
9.2.2 Asia Pediatric Drugs Revenue by Application (2018-2029)
9.3 Asia Pediatric Drugs Sales by Region
9.3.1 Asia Pediatric Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pediatric Drugs Revenue by Region (2018-2029)
9.3.3 Asia Pediatric Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pediatric Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Pediatric Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pediatric Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pediatric Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Pediatric Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pediatric Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pediatric Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Pediatric Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pediatric Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pediatric Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Overview
11.1.3 Abbott Laboratories Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Abbott Laboratories Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Laboratories Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Bayer Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Boehringer Ingelheim Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Overview
11.4.3 Bristol-Myers Squibb Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Bristol-Myers Squibb Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bristol-Myers Squibb Recent Developments
11.5 Colgate Oral Pharmaceuticals
11.5.1 Colgate Oral Pharmaceuticals Company Information
11.5.2 Colgate Oral Pharmaceuticals Overview
11.5.3 Colgate Oral Pharmaceuticals Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Colgate Oral Pharmaceuticals Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Colgate Oral Pharmaceuticals Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Information
11.6.2 Eli Lilly Overview
11.6.3 Eli Lilly Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Eli Lilly Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eli Lilly Recent Developments
11.7 Forest Laboratories
11.7.1 Forest Laboratories Company Information
11.7.2 Forest Laboratories Overview
11.7.3 Forest Laboratories Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Forest Laboratories Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Forest Laboratories Recent Developments
11.8 Genentech
11.8.1 Genentech Company Information
11.8.2 Genentech Overview
11.8.3 Genentech Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Genentech Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genentech Recent Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Information
11.9.2 GlaxoSmithKline Overview
11.9.3 GlaxoSmithKline Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 GlaxoSmithKline Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 GlaxoSmithKline Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Information
11.10.2 Johnson & Johnson Overview
11.10.3 Johnson & Johnson Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Johnson & Johnson Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Johnson & Johnson Recent Developments
11.11 MedImmune
11.11.1 MedImmune Company Information
11.11.2 MedImmune Overview
11.11.3 MedImmune Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 MedImmune Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 MedImmune Recent Developments
11.12 Merck
11.12.1 Merck Company Information
11.12.2 Merck Overview
11.12.3 Merck Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Merck Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Merck Recent Developments
11.13 Novartis Pharmaceuticals
11.13.1 Novartis Pharmaceuticals Company Information
11.13.2 Novartis Pharmaceuticals Overview
11.13.3 Novartis Pharmaceuticals Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Novartis Pharmaceuticals Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Novartis Pharmaceuticals Recent Developments
11.14 Novo Nordisk
11.14.1 Novo Nordisk Company Information
11.14.2 Novo Nordisk Overview
11.14.3 Novo Nordisk Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Novo Nordisk Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Novo Nordisk Recent Developments
11.15 Pfizer
11.15.1 Pfizer Company Information
11.15.2 Pfizer Overview
11.15.3 Pfizer Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Pfizer Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Pfizer Recent Developments
11.16 Pharmacia
11.16.1 Pharmacia Company Information
11.16.2 Pharmacia Overview
11.16.3 Pharmacia Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Pharmacia Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Pharmacia Recent Developments
11.17 Roche
11.17.1 Roche Company Information
11.17.2 Roche Overview
11.17.3 Roche Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Roche Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Roche Recent Developments
11.18 Schering-Plough
11.18.1 Schering-Plough Company Information
11.18.2 Schering-Plough Overview
11.18.3 Schering-Plough Pediatric Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Schering-Plough Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Schering-Plough Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pediatric Drugs Industry Chain Analysis
12.2 Pediatric Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pediatric Drugs Production Mode & Process
12.4 Pediatric Drugs Sales and Marketing
12.4.1 Pediatric Drugs Sales Channels
12.4.2 Pediatric Drugs Distributors
12.5 Pediatric Drugs Customers
13 Market Dynamics
13.1 Pediatric Drugs Industry Trends
13.2 Pediatric Drugs Market Drivers
13.3 Pediatric Drugs Market Challenges
13.4 Pediatric Drugs Market Restraints
14 Key Findings in The Global Pediatric Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Pediatric Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Allergy and Respiratory Drugs
Table 3. Major Manufacturers of Anti-Infectives
Table 4. Major Manufacturers of Cancer Therapies
Table 5. Major Manufacturers of Cardiovascular Drugs
Table 6. Major Manufacturers of Central Nervous System Drugs
Table 7. Major Manufacturers of Gastrointestinal Drugs
Table 8. Major Manufacturers of Hormone Drugs
Table 9. Major Manufacturers of Urological Drugs
Table 10. Global Pediatric Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Pediatric Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Pediatric Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 13. Global Pediatric Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 14. Global Pediatric Drugs Revenue Market Share by Region (2018-2023)
Table 15. Global Pediatric Drugs Revenue Market Share by Region (2024-2029)
Table 16. Global Pediatric Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 17. Global Pediatric Drugs Sales by Region (2018-2023) & (K Units)
Table 18. Global Pediatric Drugs Sales by Region (2024-2029) & (K Units)
Table 19. Global Pediatric Drugs Sales Market Share by Region (2018-2023)
Table 20. Global Pediatric Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Pediatric Drugs Sales by Manufacturers (2018-2023) & (K Units)
Table 22. Global Pediatric Drugs Sales Share by Manufacturers (2018-2023)
Table 23. Global Pediatric Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 24. Global Pediatric Drugs Revenue Share by Manufacturers (2018-2023)
Table 25. Global Key Players of Pediatric Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 26. Pediatric Drugs Price by Manufacturers 2018-2023 (USD/Unit)
Table 27. Global Pediatric Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Pediatric Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Drugs as of 2022)
Table 29. Global Key Manufacturers of Pediatric Drugs, Manufacturing Base Distribution and Headquarters
Table 30. Global Key Manufacturers of Pediatric Drugs, Product Offered and Application
Table 31. Global Key Manufacturers of Pediatric Drugs, Date of Enter into This Industry
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Pediatric Drugs Sales by Type (2018-2023) & (K Units)
Table 34. Global Pediatric Drugs Sales by Type (2024-2029) & (K Units)
Table 35. Global Pediatric Drugs Sales Share by Type (2018-2023)
Table 36. Global Pediatric Drugs Sales Share by Type (2024-2029)
Table 37. Global Pediatric Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 38. Global Pediatric Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 39. Global Pediatric Drugs Revenue Share by Type (2018-2023)
Table 40. Global Pediatric Drugs Revenue Share by Type (2024-2029)
Table 41. Pediatric Drugs Price by Type (2018-2023) & (USD/Unit)
Table 42. Global Pediatric Drugs Price Forecast by Type (2024-2029) & (USD/Unit)
Table 43. Global Pediatric Drugs Sales by Application (2018-2023) & (K Units)
Table 44. Global Pediatric Drugs Sales by Application (2024-2029) & (K Units)
Table 45. Global Pediatric Drugs Sales Share by Application (2018-2023)
Table 46. Global Pediatric Drugs Sales Share by Application (2024-2029)
Table 47. Global Pediatric Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 48. Global Pediatric Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 49. Global Pediatric Drugs Revenue Share by Application (2018-2023)
Table 50. Global Pediatric Drugs Revenue Share by Application (2024-2029)
Table 51. Pediatric Drugs Price by Application (2018-2023) & (USD/Unit)
Table 52. Global Pediatric Drugs Price Forecast by Application (2024-2029) & (USD/Unit)
Table 53. US & Canada Pediatric Drugs Sales by Type (2018-2023) & (K Units)
Table 54. US & Canada Pediatric Drugs Sales by Type (2024-2029) & (K Units)
Table 55. US & Canada Pediatric Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 56. US & Canada Pediatric Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 57. US & Canada Pediatric Drugs Sales by Application (2018-2023) & (K Units)
Table 58. US & Canada Pediatric Drugs Sales by Application (2024-2029) & (K Units)
Table 59. US & Canada Pediatric Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 60. US & Canada Pediatric Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 61. US & Canada Pediatric Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 62. US & Canada Pediatric Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 63. US & Canada Pediatric Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 64. US & Canada Pediatric Drugs Sales by Country (2018-2023) & (K Units)
Table 65. US & Canada Pediatric Drugs Sales by Country (2024-2029) & (K Units)
Table 66. Europe Pediatric Drugs Sales by Type (2018-2023) & (K Units)
Table 67. Europe Pediatric Drugs Sales by Type (2024-2029) & (K Units)
Table 68. Europe Pediatric Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 69. Europe Pediatric Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 70. Europe Pediatric Drugs Sales by Application (2018-2023) & (K Units)
Table 71. Europe Pediatric Drugs Sales by Application (2024-2029) & (K Units)
Table 72. Europe Pediatric Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 73. Europe Pediatric Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 74. Europe Pediatric Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 75. Europe Pediatric Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 76. Europe Pediatric Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 77. Europe Pediatric Drugs Sales by Country (2018-2023) & (K Units)
Table 78. Europe Pediatric Drugs Sales by Country (2024-2029) & (K Units)
Table 79. China Pediatric Drugs Sales by Type (2018-2023) & (K Units)
Table 80. China Pediatric Drugs Sales by Type (2024-2029) & (K Units)
Table 81. China Pediatric Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 82. China Pediatric Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 83. China Pediatric Drugs Sales by Application (2018-2023) & (K Units)
Table 84. China Pediatric Drugs Sales by Application (2024-2029) & (K Units)
Table 85. China Pediatric Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 86. China Pediatric Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 87. Asia Pediatric Drugs Sales by Type (2018-2023) & (K Units)
Table 88. Asia Pediatric Drugs Sales by Type (2024-2029) & (K Units)
Table 89. Asia Pediatric Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 90. Asia Pediatric Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 91. Asia Pediatric Drugs Sales by Application (2018-2023) & (K Units)
Table 92. Asia Pediatric Drugs Sales by Application (2024-2029) & (K Units)
Table 93. Asia Pediatric Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 94. Asia Pediatric Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 95. Asia Pediatric Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Asia Pediatric Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 97. Asia Pediatric Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 98. Asia Pediatric Drugs Sales by Region (2018-2023) & (K Units)
Table 99. Asia Pediatric Drugs Sales by Region (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Pediatric Drugs Sales by Type (2018-2023) & (K Units)
Table 101. Middle East, Africa and Latin America Pediatric Drugs Sales by Type (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Pediatric Drugs Revenue by Type (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Pediatric Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pediatric Drugs Sales by Application (2018-2023) & (K Units)
Table 105. Middle East, Africa and Latin America Pediatric Drugs Sales by Application (2024-2029) & (K Units)
Table 106. Middle East, Africa and Latin America Pediatric Drugs Revenue by Application (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Pediatric Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Pediatric Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 109. Middle East, Africa and Latin America Pediatric Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Pediatric Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 111. Middle East, Africa and Latin America Pediatric Drugs Sales by Country (2018-2023) & (K Units)
Table 112. Middle East, Africa and Latin America Pediatric Drugs Sales by Country (2024-2029) & (K Units)
Table 113. Abbott Laboratories Company Information
Table 114. Abbott Laboratories Description and Major Businesses
Table 115. Abbott Laboratories Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Abbott Laboratories Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Abbott Laboratories Recent Developments
Table 118. Bayer Company Information
Table 119. Bayer Description and Major Businesses
Table 120. Bayer Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Bayer Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Bayer Recent Developments
Table 123. Boehringer Ingelheim Company Information
Table 124. Boehringer Ingelheim Description and Major Businesses
Table 125. Boehringer Ingelheim Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Boehringer Ingelheim Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Boehringer Ingelheim Recent Developments
Table 128. Bristol-Myers Squibb Company Information
Table 129. Bristol-Myers Squibb Description and Major Businesses
Table 130. Bristol-Myers Squibb Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Bristol-Myers Squibb Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Bristol-Myers Squibb Recent Developments
Table 133. Colgate Oral Pharmaceuticals Company Information
Table 134. Colgate Oral Pharmaceuticals Description and Major Businesses
Table 135. Colgate Oral Pharmaceuticals Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Colgate Oral Pharmaceuticals Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Colgate Oral Pharmaceuticals Recent Developments
Table 138. Eli Lilly Company Information
Table 139. Eli Lilly Description and Major Businesses
Table 140. Eli Lilly Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. Eli Lilly Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Eli Lilly Recent Developments
Table 143. Forest Laboratories Company Information
Table 144. Forest Laboratories Description and Major Businesses
Table 145. Forest Laboratories Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 146. Forest Laboratories Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Forest Laboratories Recent Developments
Table 148. Genentech Company Information
Table 149. Genentech Description and Major Businesses
Table 150. Genentech Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 151. Genentech Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Genentech Recent Developments
Table 153. GlaxoSmithKline Company Information
Table 154. GlaxoSmithKline Description and Major Businesses
Table 155. GlaxoSmithKline Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 156. GlaxoSmithKline Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. GlaxoSmithKline Recent Developments
Table 158. Johnson & Johnson Company Information
Table 159. Johnson & Johnson Description and Major Businesses
Table 160. Johnson & Johnson Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 161. Johnson & Johnson Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Johnson & Johnson Recent Developments
Table 163. MedImmune Company Information
Table 164. MedImmune Description and Major Businesses
Table 165. MedImmune Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 166. MedImmune Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. MedImmune Recent Developments
Table 168. Merck Company Information
Table 169. Merck Description and Major Businesses
Table 170. Merck Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 171. Merck Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. Merck Recent Developments
Table 173. Novartis Pharmaceuticals Company Information
Table 174. Novartis Pharmaceuticals Description and Major Businesses
Table 175. Novartis Pharmaceuticals Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 176. Novartis Pharmaceuticals Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Novartis Pharmaceuticals Recent Developments
Table 178. Novo Nordisk Company Information
Table 179. Novo Nordisk Description and Major Businesses
Table 180. Novo Nordisk Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 181. Novo Nordisk Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Novo Nordisk Recent Developments
Table 183. Pfizer Company Information
Table 184. Pfizer Description and Major Businesses
Table 185. Pfizer Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 186. Pfizer Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 187. Pfizer Recent Developments
Table 188. Pharmacia Company Information
Table 189. Pharmacia Description and Major Businesses
Table 190. Pharmacia Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 191. Pharmacia Pediatric Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 192. Pharmacia Recent Developments
Table 193. Roche Company Information
Table 194. Roche Description and Major Businesses
Table 195. Roche Pediatric Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 196. Roche Pediatric Drugs Product Model Numbers, Pictures, Descrip
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs